Skip to main content
Clinical Trials/ACTRN12613000444785
ACTRN12613000444785Recruiting未知

Implications of aggressive cardiac risk factor management on the catheter ablation for atrial fibrillation

Royal Melbourne Hospital0 sites150 target enrollmentStarted: April 18, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Recruiting
Enrollment
150

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to 65 Years (—)
Sex
All

Inclusion Criteria

  • •Paroxysmal and persistent AF
  • •Waist circumference >100 (male), >90 (female)
  • •Highly symptomatic AF
  • •Age >18 years and <65 years

Exclusion Criteria

  • •Serious underlying medical disorder
  • •Malabsorption disorder
  • •Unstable INR
  • •Moderate-severe impaired LV systolic function
  • •Insulin-dependent diabetes
  • •Moderate-severe cardiac valvulopathy
  • •Inability to provide informed consent
  • •Endocrinopathy including subclinical thyroid disease
  • •Recent (within 3 months) participation in a structured weight management program
  • •Significant psychiatric disorder

Investigators

Similar Trials